Take-Two (TTWO) Director Granted 346 Shares; 254 Time-Vested, 92 Vested at Grant
Rhea-AI Filing Summary
Take-Two Interactive director Paul E. Viera acquired 346 restricted shares of the issuer's common stock on 08/14/2025 under the director compensation program and the 2017 Stock Incentive Plan, with the grant date and share count determined using the average closing price over the 30 trading days before the Pricing Date. The grant includes 254 restricted shares that vest on the first anniversary of the Pricing Date and 92 shares granted in lieu of cash that were fully vested upon grant. Following the reported transaction, Mr. Viera directly beneficially owned 15,937 shares. He also has indirect holdings of 74 shares held by Earnest Institutional LLC and 75,000 shares held by The PEV Revocable Living Trust, as disclosed on the form.
Positive
- Acquisition of 346 restricted shares under the director compensation program, including 254 shares that vest after one year
- 92 shares granted in lieu of cash were fully vested upon grant, increasing immediate vested holdings
- Transparent disclosure of indirect holdings: 74 shares via Earnest Institutional LLC and 75,000 shares via The PEV Revocable Living Trust
Negative
- None.
Insights
TL;DR Routine director equity grant aligns director compensation with shareholder interests without indicating material change.
The filing documents a standard director equity award under the companys director compensation program and stock plan. The award structure—restricted shares with a one-year vest for a portion and fully vested shares in lieu of cash—follows common governance practices to align outside directors with long-term shareholder value. The disclosure of indirect holdings by affiliated entities is complete and consistent with reporting norms.
TL;DR Non-derivative acquisition is small in absolute terms and appears administrative rather than market-moving.
The reported acquisition of 346 shares and the resulting direct beneficial ownership of 15,937 shares is modest relative to typical institutional stakes and does not reflect option exercises or cash purchases. The form clarifies vesting schedules and the grant valuation methodology tied to a 30-day average price, which is helpful for transparency. Indirect holdings of 75,074 shares via related entities are disclosed and properly disclaimed where applicable.